U.S. panel against routine PSA prostate cancer screening
Routinely screening men for prostate cancer with PSA tests can result in far more harm than good, says a U.S. expert panel in a recommendation against the practice that is sure to fuel continued debate over the issue. (Source: CTV Health)div id=medwormpbiMedWorm Sponsor Message:/i/b Have a look at a href=http://www.thepsychologydaily.comThe Psychology Daily/a, the new psychology portal powered by MedWorm, with all the latest psychology news and research updated daily./p/div

Depomed Files Patent Infringement Lawsuit Against Lupin Limited
MENLO PARK, Calif.--(HSMN NewsFeed)--Depomed, Inc. (Nasdaq:DEPO ) today announced that it has filed a lawsuit in the United States District Court for the Northern District of California against Lupin Limited and its wholly-owned subsidiary, Lupin Pharmaceu... Biopharmaceuticals, Generics, Litigation, FDADepomed, Lupin Pharmaceuticals, GLUMETZA, metformin (Source: HSMN NewsFeed)